株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

自己免疫疾患診断の世界市場:製品別 (消耗品・アッセイキット、診断装置)・検査の種類別 (炎症性マーカー、日常検査)・疾患別 (RA、SLE、甲状腺炎、強皮症)・エンドユーザー別の将来予測 (2025年まで)

Autoimmune Disease Diagnosis Market by Product (Consumables, Assay Kits, Instruments), Test Type (Inflammatory Markers, Routine Laboratory Tests), Disease (RA, SLE, Thyroiditis, Scleroderma), End User - Global Forecast to 2025

発行 MarketsandMarkets 商品コード 932349
出版日 ページ情報 英文 151 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.30円で換算しております。
自己免疫疾患診断の世界市場:製品別 (消耗品・アッセイキット、診断装置)・検査の種類別 (炎症性マーカー、日常検査)・疾患別 (RA、SLE、甲状腺炎、強皮症)・エンドユーザー別の将来予測 (2025年まで) Autoimmune Disease Diagnosis Market by Product (Consumables, Assay Kits, Instruments), Test Type (Inflammatory Markers, Routine Laboratory Tests), Disease (RA, SLE, Thyroiditis, Scleroderma), End User - Global Forecast to 2025
出版日: 2020年04月10日 ページ情報: 英文 151 Pages
概要

世界の自己免疫疾患診断の市場規模は、2020年の41億米ドルから2025年には63億米ドルへと、8.9%のCAGRで拡大する、と予測されています。慢性疾患の発生率の上昇や費用対効果の高さなどが、市場成長の大きな要因として挙げられています。他方、製造工程の複雑さが市場成長の制約要因となっています。製品別では消耗品・アセットキットが、検査の種類別ではルーチン検査向け需要が、地域別ではアジア太平洋地域が今後大きく成長する見通しです。

当レポートでは、世界の自己免疫疾患診断の市場について分析し、市場の基本構造や最新情勢、主な市場促進・阻害要因、市場動向の見通し (今後6年間分)、製品別・検査の種類別・疾患別・エンドユーザー別・地域別の詳細動向、市場競争の状態、主要企業のプロファイルなどを調査しております。

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概略

  • イントロダクション
  • 市場のダイナミクス
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 傾向

第6章 自己免疫疾患診断の市場:製品別

  • イントロダクション
  • 消耗品・アッセイキット
  • 診断装置

第7章 自己免疫疾患診断の市場:検査の種類別

  • イントロダクション
  • 日常検査
  • 炎症マーカー
  • 自己抗体・免疫検査
  • その他の検査

第8章 自己免疫疾患診断の市場:疾患別

  • イントロダクション
  • リウマチ性関節炎
  • 全身性エリテマトーデス
  • シェーグレン症候群
  • 甲状腺炎
  • 強皮症
  • その他の疾患

第9章 自己免疫疾患診断の市場:エンドユーザー別

  • イントロダクション
  • 臨床検査室
  • 病院
  • その他のエンドユーザー

第10章 自己免疫疾患診断の市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州諸国
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他のアジア太平洋諸国
  • 中東・アフリカ
  • ラテンアメリカ

第11章 競争環境

  • 概要
  • 市場シェア分析 (2018年)
  • 競争シナリオ
    • 製品の発売 (2017~2020年)
    • 製品の認証 (2017~2020年)
    • 事業提携
    • 企業買収 (2017~2020年)
    • 事業協力 (2017~2020年)
  • 企業戦略の方向性:マッピング
    • 先駆的企業
    • 革新的企業
    • 活動的企業
    • 新規企業

第12章 企業プロファイル

  • THERMO FISHER SCIENTIFIC
  • SIEMENS
  • ABBOTT
  • DANAHER
  • BIO-RAD LABORATORIES
  • GRIFOLS
  • TRINITY BIOTECH
  • WERFEN
  • HYCOR BIOMEDICAL
  • EUROIMMUN
  • ONCIMMUNE
  • HTG MOLECULAR DIAGNOSTICS, INC.
  • SERAMUN DIAGNOSTICA GMBH
  • EXAGEN INC.
  • CAMBRIDGE LIFE SCIENCES LIMITED
  • A. MENARINI DIAGNOSTICS S.R.L
  • ORGENTEC DIAGNOSTIKA
  • KRONUS
  • ERBA GROUP
  • AESKU.GROUP GMBH & CO. KG

第13章 付録

図表

LIST OF TABLES

  • TABLE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 39
  • TABLE 2 AUTOIMMUNE DISEASE DIAGNOSIS CONSUMABLES & ASSAY KITS MARKET, BY REGION, 2018-2025 (USD MILLION) 40
  • TABLE 3 AUTOIMMUNE DISEASE DIAGNOSIS INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION) 41
  • TABLE 4 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 43
  • TABLE 5 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR ROUTINE LABORATORY TESTS, BY REGION, 2018-2025 (USD MILLION) 44
  • TABLE 6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR INFLAMMATORY MARKERS, BY REGION, 2018-2025 (USD MILLION) 45
  • TABLE 7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR AUTOANTIBODIES AND IMMUNOLOGIC TESTS, BY REGION, 2018-2025 (USD MILLION) 46
  • TABLE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER TESTS, BY REGION, 2018-2025 (USD MILLION) 46
  • TABLE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 48
  • TABLE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2018-2025 (USD MILLION) 49
  • TABLE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2025 (USD MILLION) 50
  • TABLE 12 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SJOGREN'S SYNDROME, BY REGION, 2018-2025 (USD MILLION) 51
  • TABLE 13 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR THYROIDITIS, BY REGION, 2018-2025 (USD MILLION) 52
  • TABLE 14 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR SCLERODERMA, BY REGION, 2018-2025 (USD MILLION) 52
  • TABLE 15 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER DISEASES, BY REGION, 2018-2025 (USD MILLION) 53
  • TABLE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 55
  • TABLE 17 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2018-2025 (USD MILLION) 56
  • TABLE 18 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR HOSPITALS, BY REGION, 2018-2025 (USD MILLION) 57
  • TABLE 19 AUTOIMMUNE DISEASE DIAGNOSIS MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION) 57
  • TABLE 20 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION, 2018-2025 (USD MILLION) 59
  • TABLE 21 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 60
  • TABLE 22 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 61
  • TABLE 23 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 61
  • TABLE 24 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 61
  • TABLE 25 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 62
  • TABLE 26 EXPENDITURE ON AUTOIMMUNE DISEASE R&D BY THE NATIONAL INSTITUTES OF HEALTH, 2016-2019 62
  • TABLE 27 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 63
  • TABLE 28 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 63
  • TABLE 29 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 63
  • TABLE 30 US: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 64
  • TABLE 31 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 64
  • TABLE 32 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 65
  • TABLE 33 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 65
  • TABLE 34 CANADA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 65
  • TABLE 35 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 68
  • TABLE 36 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 68
  • TABLE 37 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 68
  • TABLE 38 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 69
  • TABLE 39 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 69
  • TABLE 40 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 70
  • TABLE 41 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 70
  • TABLE 42 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 70
  • TABLE 43 GERMANY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 71
  • TABLE 44 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 71
  • TABLE 45 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 72
  • TABLE 46 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 72
  • TABLE 47 UK: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 72
  • TABLE 48 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 73
  • TABLE 49 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 73
  • TABLE 50 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 74
  • TABLE 51 FRANCE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 74
  • TABLE 52 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 75
  • TABLE 53 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 75
  • TABLE 54 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 75
  • TABLE 55 ITALY: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 76
  • TABLE 56 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 76
  • TABLE 57 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 76
  • TABLE 58 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 77
  • TABLE 59 SPAIN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 77
  • TABLE 60 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 78
  • TABLE 61 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 78
  • TABLE 62 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 78
  • TABLE 63 REST OF EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 79
  • TABLE 64 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 80
  • TABLE 65 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 81
  • TABLE 66 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 81
  • TABLE 67 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 81
  • TABLE 68 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 82
  • TABLE 69 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 82
  • TABLE 70 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 83
  • TABLE 71 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 83
  • TABLE 72 CHINA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 83
  • TABLE 73 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 84
  • TABLE 74 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 84
  • TABLE 75 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 85
  • TABLE 76 INDIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 85
  • TABLE 77 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 86
  • TABLE 78 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 86
  • TABLE 79 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 86
  • TABLE 80 JAPAN: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 87
  • TABLE 81 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 87
  • TABLE 82 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 88
  • TABLE 83 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 88
  • TABLE 84 AUSTRALIA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 88
  • TABLE 85 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 89
  • TABLE 86 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 89
  • TABLE 87 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 90
  • TABLE 88 REST OF ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 90
  • TABLE 89 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 91
  • TABLE 90 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 91
  • TABLE 91 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 91
  • TABLE 92 MIDDLE EAST & AFRICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 92
  • TABLE 93 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2018-2025 (USD MILLION) 92
  • TABLE 94 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2018-2025 (USD MILLION) 93
  • TABLE 95 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2018-2025 (USD MILLION) 93
  • TABLE 96 LATIN AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2018-2025 (USD MILLION) 93

LIST OF FIGURES

  • FIGURE 1 AUTOIMMUNE DISEASE DIAGNOSIS MARKET SEGMENTATION 18
  • FIGURE 2 RESEARCH DESIGN 20
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22
  • FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 22
  • FIGURE 5 MARKET SIZE ESTIMATION FROM THE PARENT MARKET 23
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY 24
  • FIGURE 7 ASSUMPTIONS FOR THE STUDY 25
  • FIGURE 8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION) 26
  • FIGURE 9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE, 2020 VS. 2025 (USD MILLION) 27
  • FIGURE 10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE, 2020 VS. 2025 (USD MILLION) 27
  • FIGURE 11 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 28
  • FIGURE 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET 29
  • FIGURE 13 HIGH INCIDENCE & LARGE ECONOMIC BURDEN OF AUTOIMMUNE DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 30
  • FIGURE 14 RHEUMATOID ARTHRITIS SEGMENT DOMINATED THE APAC MARKET IN 2019 31
  • FIGURE 15 JAPAN TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 32
  • FIGURE 16 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & TRENDS 33
  • FIGURE 17 NORTH AMERICA: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT 60
  • FIGURE 18 EUROPE: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT 67
  • FIGURE 19 ASIA PACIFIC: AUTOIMMUNE DISEASE DIAGNOSIS MARKET SNAPSHOT 80
  • FIGURE 20 PRODUCT LAUNCHES-THE MOST ADOPTED GROWTH STRATEGY FROM 2017 TO 2020 94
  • FIGURE 21 SHARES OF TOP COMPANIES IN THE GLOBAL AUTOIMMUNE DISEASE DIAGNOSIS MARKET (2018) 95
  • FIGURE 22 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2018 100
  • FIGURE 23 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 101
  • FIGURE 24 SIEMENS: COMPANY SNAPSHOT 104
  • FIGURE 25 ABBOTT: COMPANY SNAPSHOT 106
  • FIGURE 26 DANAHER: COMPANY SNAPSHOT 109
  • FIGURE 27 BIO-RAD LABORATORIES: COMPANY SNAPSHOT 111
  • FIGURE 28 GRIFOLS: COMPANY SNAPSHOT 114
  • FIGURE 29 TRINITY BIOTECH: COMPANY SNAPSHOT 116
  • FIGURE 30 WERFEN: COMPANY SNAPSHOT 118
  • FIGURE 31 PERKINELMER, INC.: COMPANY SNAPSHOT 122  
  • FIGURE 32 ONCIMMUNE: COMPANY SNAPSHOT 127
  • FIGURE 33 HTG MOLECULAR DIAGNOSTICS, INC.: COMPANY SNAPSHOT 129
  • FIGURE 34 EXAGEN INC.: COMPANY SNAPSHOT 132
目次
Product Code: MD 5936

"The global autoimmune disease diagnosis market size is projected to register a CAGR of 8.9% during the forecast period."

The global autoimmune disease diagnosis market size is projected to reach USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%. Growth in this industry is driven by the rising incidence of chronic diseases and the increasing demand for autoimmune disease diagnosis due to their cost-effectiveness. On the other hand, complexities in manufacturing restraining the market.

"The consumables &assay kits segment is anticipated to grow at the fastest growth rate during the forecast period."

The autoimmune disease diagnosis market by product is categorized into consumables & assay kits and instruments. The consumables & assay kits segment is expected to register the highest CAGR during the forecast period. The growth of this segment is driven mainly by the increasing number of product launches/approvals, rising incidences of autoimmune diseases.

"The routine laboratory tests segment is estimated to grow at a rapid rate during the analysis period."

Based on the test type, the autoimmune disease diagnosis market is segmented into routine laboratory tests, inflammatory markers, autoantibodies & immunologic tests, and other tests. The routine laboratory tests segment is expected to remain the fastest-growing segment of the global market during the autoimmune disease diagnosis period. The increasing number of regular health checkups, growing government initiatives to promote the importance of early disease diagnosis, are driving growth.

"Asia Pacific is estimated to register the highest CAGR during the study period."

Geographically, the autoimmune disease diagnosis market is dominated by Europe and followed by North America in 2019. However, the Asia Pacific region is estimated to grow at the fastest rate during forecast to period. The rising aging population, coupled with the massive demand for effective diagnosis of autoimmune diseases, will drive the market in the region over the forecast period.

Breakdown of Profiles of Primary Participants:

  • By Company Type: Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
  • By Designation: C-level: 30%, Director-level: 34%, and Others: 36%
  • By Region: North America: 40%, Europe: 28%, Asia Pacific: 20%, and the Rest of the World: 12%

The key players in the autoimmune disease diagnosis market include: Thermo Fisher Scientific (US), Siemens (Germany), Abbott (US), Danaher (US), Bio-Rad Laboratories (US), Grifols (Spain), Trinity Biotech (Ireland), Werfen (Spain), HYCOR Biomedical (US), EUROIMMUN AG (Germany), Oncimmune (UK), HTG Molecular Diagnostics (US), Seramun Diagnostica GmbH (Germany), Exagen Inc. (US), Cambridge Life Sciences Limited (UK), A. Menarini Diagnostics s.r.l (Italy), ORGENTEC Diagnostika (Germany), KRONUS (US), and AESKU GROUP GMBH & CO. KG (Germany).

Research Coverage:

The report analyzes the autoimmune disease diagnosis market by product, test type, disease, end user, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:

This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one, or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the services of the top players in the autoimmune disease diagnosis market
  • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the autoimmune disease diagnosis market
  • Market Development: Detailed information about emerging markets.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the autoimmune disease diagnosis market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 GROWTH FORECAST
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE MARKET OPPORTUNITIES IN THE AUTOIMMUNE DISEASE DIAGNOSIS MARKET
  • 4.2 ASIA PACIFIC MARKET: BY DISEASE
  • 4.3 AUTOIMMUNE DISEASE DIAGNOSIS MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 High incidence and prevalence of autoimmune diseases
      • 5.2.1.2 Increasing awareness about autoimmune diseases
      • 5.2.1.3 Growth in the number of research activities on autoimmune diseases
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High capital requirements
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Use of biosensors for autoimmune disease diagnosis
    • 5.2.4 TRENDS
      • 5.2.4.1 Growth in the number of reagent rental agreements

6 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES & ASSAY KITS
    • 6.2.1 NEED FOR THE RAPID DETECTION OF AUTOIMMUNE DISEASES TO DRIVE THE DEMAND FOR CONSUMABLES AND ASSAY KITS
  • 6.3 INSTRUMENTS
    • 6.3.1 INSTRUMENTS SEGMENT TO RECORD SIGNIFICANT GROWTH DURING THE FORECAST PERIOD

7 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
  • 7.2 ROUTINE LABORATORY TESTS
    • 7.2.1 RISING NUMBER OF ROUTINE HEALTH CHECK-UPS TO SUPPORT MARKET GROWTH
  • 7.3 INFLAMMATORY MARKERS
    • 7.3.1 ABILITY OF INFLAMMATORY MARKERS TO DETECT ABNORMALITIES EFFICIENTLY TO DRIVE THEIR DEMAND
  • 7.4 AUTOANTIBODIES AND IMMUNOLOGIC TESTS
    • 7.4.1 ADOPTION OF NOVEL IMMUNOLOGY TESTS TO DRIVE MARKET GROWTH
  • 7.5 OTHER TESTS

8 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY DISEASE

  • 8.1 INTRODUCTION
  • 8.2 RHEUMATOID ARTHRITIS
    • 8.2.1 INCREASING INCIDENCE OF RHEUMATOID ARTHRITIS TO SUPPORT MARKET GROWTH
  • 8.3 SYSTEMIC LUPUS ERYTHEMATOSUS
    • 8.3.1 RISING PREVALENCE OF LUPUS TO SUPPORT MARKET GROWTH
  • 8.4 SJOGREN'S SYNDROME
    • 8.4.1 RISING AWARENESS REGARDING SJOGREN'S SYNDROME TO SUPPORT MARKET GROWTH
  • 8.5 THYROIDITIS
    • 8.5.1 RISING PREVALENCE OF THYROID DISORDERS TO DRIVE MARKET GROWTH
  • 8.6 SCLERODERMA
    • 8.6.1 INCREASING INCIDENCE OF SKIN DISORDERS TO DRIVE MARKET GROWTH
  • 8.7 OTHER DISEASES

9 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 CLINICAL LABORATORIES
    • 9.2.1 INCREASING INCIDENCE OF AUTOIMMUNE DISEASES TO INCREASE TESTING VOLUME IN CLINICAL LABORATORIES
  • 9.3 HOSPITALS
    • 9.3.1 INCREASING GOVERNMENT INITIATIVES TO PROVIDE QUALITY TREATMENT FOR AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH
  • 9.4 OTHER END USERS

10 AUTOIMMUNE DISEASE DIAGNOSIS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 US
      • 10.2.1.1 Rising expenditure on autoimmune disease R&D to drive market growth in the US
    • 10.2.2 CANADA
      • 10.2.2.1 Rising prevalence of autoimmune diseases to support market growth
  • 10.3 EUROPE
    • 10.3.1 GERMANY
      • 10.3.1.1 Rising healthcare expenditure to drive market growth in Germany
    • 10.3.2 UK
      • 10.3.2.1 Rising prevalence of autoimmune diseases to drive market growth in the UK
    • 10.3.3 FRANCE
      • 10.3.3.1 High prevalence of multiple sclerosis to drive market growth in France
    • 10.3.4 ITALY
      • 10.3.4.1 Increasing life science R&D expenditure to support market growth in Italy
    • 10.3.5 SPAIN
      • 10.3.5.1 Research activities conducted in the country to drive market growth in Spain
    • 10.3.6 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
      • 10.4.1.1 Outbreak of COVID-19 to hamper market growth during the forecast period
    • 10.4.2 INDIA
      • 10.4.2.1 Development of antibody tests to support market growth in India
    • 10.4.3 JAPAN
      • 10.4.3.1 Rising healthcare expenditure to support market growth in Japan
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Rising prevalence of autoimmune diseases to drive market growth in Australia
    • 10.4.5 REST OF ASIA PACIFIC
  • 10.5 MIDDLE EAST & AFRICA
    • 10.5.1 RISING INCIDENCE OF AUTOIMMUNE DISEASES TO SUPPORT MARKET GROWTH IN THE MIDDLE EAST AND AFRICA
  • 10.6 LATIN AMERICA
    • 10.6.1 HIGH PREVALENCE OF RHEUMATOID ARTHRITIS TO SUPPORT MARKET GROWTH IN LATIN AMERICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 MARKET SHARE ANALYSIS, 2018
  • 11.3 COMPETITIVE SCENARIO
    • 11.3.1 PRODUCT LAUNCHES (2017-2020)
    • 11.3.2 PRODUCT APPROVALS (2017-2020)
    • 11.3.3 PARTNERSHIPS
    • 11.3.4 ACQUISITIONS (2017-2020)
    • 11.3.5 COLLABORATIONS (2017-2020)
  • 11.4 COMPETITIVE LEADERSHIP MAPPING (2018)
    • 11.4.1 VISIONARY LEADERS
    • 11.4.2 INNOVATORS
    • 11.4.3 DYNAMIC DIFFERENTIATORS
    • 11.4.4 EMERGING COMPANIES

12 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, and MnM View)*

  • 12.1 THERMO FISHER SCIENTIFIC
  • 12.2 SIEMENS
  • 12.3 ABBOTT
  • 12.4 DANAHER
  • 12.5 BIO-RAD LABORATORIES
  • 12.6 GRIFOLS
  • 12.7 TRINITY BIOTECH
  • 12.8 WERFEN
  • 12.9 HYCOR BIOMEDICAL
  • 12.10 EUROIMMUN
  • 12.11 ONCIMMUNE
  • 12.12 HTG MOLECULAR DIAGNOSTICS, INC.
  • 12.13 SERAMUN DIAGNOSTICA GMBH
  • 12.14 EXAGEN INC.
  • 12.15 CAMBRIDGE LIFE SCIENCES LIMITED
  • 12.16 A. MENARINI DIAGNOSTICS S.R.L
  • 12.17 ORGENTEC DIAGNOSTIKA
  • 12.18 KRONUS
  • 12.19 ERBA GROUP
  • 12.20 AESKU.GROUP GMBH & CO. KG
  • Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS